According to Swedish Orphan Biovitrum's latest financial reports the company has $0.10 Billion USD in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2024-12-31 | $0.10 B | 15.2% |
2023-12-31 | $89.76 M | -31.42% |
2022-12-31 | $0.13 B | 13.31% |
2021-12-31 | $0.11 B | 134.13% |
2020-12-31 | $49.33 M | -37.45% |
2019-12-31 | $78.86 M | -76.38% |
2018-12-31 | $0.33 B | 84.77% |
2017-12-31 | $0.18 B | 108.9% |
2016-12-31 | $86.52 M | -19.48% |
2015-12-31 | $0.10 B | 60.47% |
2014-12-31 | $66.96 M | -3.54% |
2013-12-31 | $69.42 M | -1.22% |
2012-12-31 | $70.28 M | 120.64% |
2011-12-31 | $31.85 M | 458.74% |
2010-12-31 | $5.7 M | -86.84% |
2009-12-31 | $43.32 M | -26.27% |
2008-12-31 | $58.75 M | -50.09% |
2007-12-31 | $0.11 B | -10.89% |
2006-12-31 | $0.13 B | -0.66% |
2005-12-31 | $0.13 B | -15.74% |
2004-12-31 | $0.15 B | 840.18% |
2003-12-31 | $16.78 M | 38.22% |
2002-12-31 | $12.14 M |